ARQ-234
ARQ-234-131
Phase 1 mab active
Quick answer
ARQ-234 for Atopic Dermatitis (AD) is a Phase 1 program (mab) at Arcutis Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Arcutis Biotherapeutics
- Indication
- Atopic Dermatitis (AD)
- Phase
- Phase 1
- Modality
- mab
- Status
- active